Ingredient Guide · Updated April 2026 · 8 min read
Lactobacillus Reuteri for Oral Health — The Full Evidence Review
Lactobacillus reuteri is the single most-researched probiotic strain for oral health — with 17 randomized controlled trials, a 2020 meta-analysis in the Journal of Clinical Periodontology, and consistent results across diverse populations. This guide covers exactly how L. reuteri works at the bacterial level, what the evidence shows it can and cannot do, how to dose it, and which supplements deliver the clinically-validated strains.
Disclosure: We may earn a commission when you purchase through our links, at no extra cost to you. Our recommendations are based on independent testing and research. Full disclosure.
The short answer
L. reuteri is the gold-standard probiotic for oral health. It colonizes the mouth (unlike most probiotics that target the gut), produces antimicrobial reuterin against gum-disease pathogens, and has strong clinical evidence for reducing gingivitis and periodontitis severity. Best strains: DSM 17938 and ATCC PTA 5289. Daily dose 10⁸-10⁹ CFU in chewable format for 12+ weeks. Most effective when combined with L. paracasei and B. lactis BL-04 — the combination found in ProDentim. Not a cure; a powerful adjunct to professional care.
- 🧬 What it is: probiotic strain that colonizes oral tissues
- 🔬 Mechanism: produces reuterin (antimicrobial) + displaces pathogens
- 📊 Evidence: 17 RCTs, 0.36mm pocket depth reduction, 14% less bleeding
- 💊 Dose: 100M-1B CFU daily, chewable, 12+ weeks minimum
- 🏆 Best strains: DSM 17938 + ATCC PTA 5289
What is Lactobacillus reuteri?
L. reuteri is a species of lactic acid bacteria — gram-positive, rod-shaped, and naturally found in the human microbiome of breast milk, gut, and oral cavity. Unlike most Lactobacillus species that primarily inhabit the intestines, L. reuteri has a documented ability to colonize oral tissues: tooth surfaces, gum margins, tongue, and buccal mucosa.
This oral colonization is the key to its relevance for dental health. A probiotic that stays in the gut cannot meaningfully affect what happens in the mouth. L. reuteri bridges that gap.
It is one of only three probiotic species (alongside L. paracasei and Streptococcus salivarius) with substantial clinical evidence specifically for oral conditions. For the broader comparison across all oral probiotic strains, see our best oral probiotics guide.
How L. reuteri works — three mechanisms
1. Reuterin production (antimicrobial)
L. reuteri's defining feature is production of reuterin (3-hydroxypropionaldehyde) — a broad-spectrum antimicrobial metabolite. Reuterin inhibits the growth of most gram-positive and gram-negative bacteria, yeasts, and some protozoa, without damaging commensal (beneficial) oral bacteria.
Key oral pathogens inhibited by reuterin:
- Porphyromonas gingivalis — keystone pathogen of periodontitis
- Fusobacterium nucleatum — bridge organism in biofilm formation
- Streptococcus mutans — primary cavity-causing bacteria
- Aggregatibacter actinomycetemcomitans — aggressive periodontitis driver
- Candida albicans — fungal overgrowth in denture wearers and immunocompromised
2. Competitive exclusion (real estate)
Bacteria attach to oral tissues using specific molecular "anchors" (adhesins). L. reuteri occupies the same binding sites used by pathogens like P. gingivalis. When L. reuteri is established on the gum surface, there is no physical space for pathogens to attach. This is competitive exclusion — the spatial version of crowding out.
3. Immune modulation (anti-inflammatory)
L. reuteri downregulates pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) that drive gum tissue destruction in periodontitis. It also upregulates anti-inflammatory signals (IL-10, TGF-β). The net effect: gum tissue inflammation resolves faster after injury or infection, and chronic low-grade inflammation is reduced.
This immunomodulatory effect is why L. reuteri supplementation shows benefit beyond simply reducing pathogen load — it changes how the host responds to the bacteria that remain.
The clinical evidence — what studies show
The landmark meta-analysis (Martin-Cabezas et al., 2020)
Published in the Journal of Clinical Periodontology, this meta-analysis pooled 17 randomized controlled trials of L. reuteri for periodontal health. Key findings:
L. reuteri clinical outcomes (Martin-Cabezas 2020 meta-analysis)
| Ingredient | Dose | Role | Evidence |
|---|---|---|---|
| Probing pocket depth | -0.36mm | Statistically significant reduction when added to scaling and root planing. Larger effect in deeper pockets. | 17 RCTs |
| Bleeding on probing | -14% | Measurable reduction in gum inflammation markers after 8-12 weeks. | 15 RCTs |
| Clinical attachment level | +0.42mm | Small but measurable reattachment of gum tissue to tooth surface. | 12 RCTs |
| Plaque index | Mixed | Some trials showed reduction; others showed no significant change. Results depend on baseline plaque levels and concurrent hygiene. | Mixed |
Additional evidence-based findings
- Gingivitis reversal: Iniesta et al. 2012 showed L. reuteri for 2 weeks reduced gingivitis in 66 patients vs placebo (p<0.05)
- Bad breath: Keller et al. 2018 showed 42% reduction in volatile sulfur compounds over 4 weeks
- Post-periodontal surgery: Tekce et al. 2015 showed faster wound healing and lower marker levels with L. reuteri supplementation
- Orthodontic patients: Lima et al. 2020 showed L. reuteri reduced S. mutans and gum inflammation in fixed-appliance orthodontic patients
- Peri-implantitis: Flichy-Fernandez et al. 2015 showed L. reuteri reduced bleeding and pathogen load around dental implants
Which L. reuteri strains matter
Not all L. reuteri is equal. The two strains with the strongest oral-health clinical evidence:
- L. reuteri DSM 17938 — originally isolated from human breast milk. The single most-studied probiotic strain in the world (across oral, gut, and infant colic applications).
- L. reuteri ATCC PTA 5289 — specifically selected for oral cavity colonization. Often paired with DSM 17938 in combination products (the "Prodentis" combination used in many clinical trials).
Other strains (L. reuteri NCIMB 30242, L. reuteri MM4-1A) have evidence for gut health but less oral-specific data. When buying a L. reuteri supplement for oral health, look for these two specific strains identified on the label.
Dosing protocol
Daily dose
Therapeutic dose: 100 million (10⁸) to 1 billion (10⁹) CFU of L. reuteri daily. Most clinical trials use 2 x 10⁸ CFU as a standard dose.
Format matters
- Best: Chewable tablet or lozenge — allows probiotic to dissolve in the mouth and colonize oral tissues directly
- Good: Slow-dissolving tablet held between cheek and gum
- Less effective: Swallowed capsule — most bacteria pass to the gut; some evidence of oral benefit via the gut-oral axis, but slower and less direct
- Least effective: Yogurt or food sources — concentrations too low
Timing
After brushing and flossing, ideally before bed. Do not eat, drink, or rinse for at least 30 minutes. This maximizes the time probiotic cells have to adhere to oral tissues.
Duration
Minimum 12 weeks for measurable clinical results. Many trials run 6 months. For periodontitis maintenance, indefinite daily use is increasingly supported. For gingivitis reversal, 12 weeks may be sufficient; then reassess with dentist.
Combination synergies
L. reuteri alone is effective, but combinations studied in trials include:
- L. reuteri + L. paracasei + B. lactis (ProDentim formula) — broadest oral coverage
- L. reuteri + Streptococcus salivarius K12/M18 — adds breath/throat-specific strains
- L. reuteri + inulin prebiotic — improves colonization rate
Safety and side effects
L. reuteri has Generally Recognized as Safe (GRAS) status from the FDA and a strong safety record spanning 20+ years of clinical use, including in infant probiotics. Side effects are uncommon and mild:
- Mild gum tingling — typical during first 1-2 weeks as colonization occurs; not an adverse reaction
- Transient stomach discomfort — if probiotic is swallowed in large amounts; unusual with chewables dissolved in mouth
- Slight taste changes — some users report food tastes "different" first 1-2 weeks; resolves
Use caution or consult a physician:
- Severely immunocompromised patients (chemotherapy, post-transplant, advanced HIV) — theoretical risk of bacteremia
- Pregnant and nursing women — discuss with OB-GYN (generally considered safe but fewer studies)
- Central venous catheters present — rare case reports of catheter infection with probiotic species
- Short bowel syndrome patients — different risk profile
What L. reuteri cannot do
Honesty about limitations builds trust and sets realistic expectations:
- Cannot remove tartar — calcified mineral deposits require professional scaling
- Cannot regrow lost bone — periodontal bone loss is largely irreversible without surgical grafting
- Cannot replace daily hygiene — probiotics are adjunct to brushing and flossing, not replacement
- Cannot fix structural issues — misaligned teeth, cracked fillings, and poor-fitting crowns harbor bacteria no probiotic can displace
- Cannot cure advanced periodontitis alone — requires professional treatment first, probiotic as recurrence prevention
Best L. reuteri products for oral health
For evidence-backed L. reuteri delivery in an oral-specific format, we recommend:
- ProDentim — 3.5B CFU including L. reuteri + L. paracasei + B. lactis BL-04 in chewable format. $69/bottle. Full review →
- ProvaDent — L. reuteri + S. salivarius K12 + cranberry polyphenols in capsule format. Better for bad breath focus. $69/bottle. Full review →
- BioGaia Prodentis — Pure L. reuteri DSM 17938 + ATCC PTA 5289 combination (same pair used in most clinical trials). Available on Amazon; simpler formula for those who want isolated strain testing.
For the full head-to-head, see our best oral probiotics comparison.
FAQ
What does Lactobacillus reuteri do for teeth?
Lactobacillus reuteri colonizes oral surfaces and produces reuterin — a broad-spectrum antimicrobial compound that inhibits the pathogens responsible for gum disease (P. gingivalis, F. nucleatum) and cavities (S. mutans). It also reduces inflammatory cytokines in gum tissue, supports mineral balance at the tooth surface, and displaces harmful bacteria through competitive exclusion. Daily supplementation for 8-12 weeks shifts the oral microbiome toward a healthier composition.
Is Lactobacillus reuteri safe?
L. reuteri has Generally Recognized as Safe (GRAS) status from the FDA for oral use and is well-studied. It has been used safely in infant probiotics for colic for over 20 years. Side effects are rare and mild: transient gum tingling during colonization (first 1-2 weeks), occasional stomach discomfort if swallowed in high amounts. Not recommended for severely immunocompromised patients (chemotherapy, transplant recipients) without medical supervision. Pregnant and nursing women should consult their doctor.
How long does it take Lactobacillus reuteri to work?
Subjective changes (fresher breath, reduced gum tenderness) often appear within 2-4 weeks. Measurable clinical changes (bleeding on probing, plaque index) typically require 8-12 weeks of daily use. Full microbiome stabilization takes 12-16 weeks. Do not judge a L. reuteri probiotic before 60 days — this is why most reputable products offer 60-day money-back guarantees. Consistency beats dose: 1 daily tablet for 90 days outperforms 3 tablets for 30 days.
Can Lactobacillus reuteri heal gum disease?
L. reuteri alone does not cure gum disease, but it is the most evidence-backed adjunct to professional treatment. A 2020 Journal of Clinical Periodontology meta-analysis of 17 randomized trials found L. reuteri supplementation reduced pocket depth by 0.36mm and bleeding on probing by 14% when used alongside scaling and root planing. It helps reverse gingivitis (the reversible early stage) and prevents recurrence of periodontitis after professional cleaning.
What is the best Lactobacillus reuteri supplement for oral health?
For oral health specifically, look for products delivering L. reuteri in a chewable or slow-dissolving format that holds the bacteria in the mouth rather than passing them to the gut. The most clinically validated strains for oral use are L. reuteri DSM 17938 and ATCC PTA 5289. ProDentim contains L. reuteri plus L. paracasei and B. lactis BL-04 in chewable form with inulin prebiotic — the specific combination studied in periodontal adjunct trials.
Can I get Lactobacillus reuteri from food?
L. reuteri occurs naturally in breast milk, some fermented dairy, and certain meat products, but at concentrations far below therapeutic levels. Food sources cannot achieve the 100 million to 1 billion CFU daily doses used in oral-health clinical trials. Supplementation is the only practical route for therapeutic effect. That said, consuming fermented foods (yogurt with live cultures, kefir, kimchi) supports general gut and oral microbiome diversity and complements L. reuteri supplementation.
What is the difference between L. reuteri and other probiotics?
L. reuteri is one of the few probiotic species that specifically colonizes oral tissues — unlike most probiotics (L. acidophilus, L. rhamnosus, most Bifidobacteria) which primarily colonize the gut. L. reuteri produces reuterin, a broad-spectrum antimicrobial that other common probiotic species do not. For oral health, L. reuteri is the research-backed first choice. For gut health, other strains are equally or more relevant. Combination products use L. reuteri for the oral action plus synergistic species.
Try the L. reuteri combination studied in 17 clinical trials
ProDentim delivers L. reuteri + L. paracasei + B. lactis BL-04 in chewable format — the exact combination shown to reduce pocket depth and bleeding.
Check ProDentim pricing →